Aida Mihajlovic
Psychiatry · Olympia Fields, ILNPI 1023063039
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by AbbVie at 52.2% of the total. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 696 payments — averaging $152.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$55K
- Johnson & Johnson$14K
- Biogen$12K
- Otsuka America Pharmaceutical, Inc.$8K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
- Teva Pharmaceuticals USA, Inc.$2K
- plus $11K from 24 others
What the payments were for
- Consulting fees$21,53120%
- Speaking & faculty fees$55,11752%
- Travel & lodging$8,7368%
- Food & beverage$20,14719%
- Education$4970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 260 | $55,294 |
| Johnson & Johnson | 48 | $14,496 |
| Biogen | 12 | $12,198 |
| Otsuka America Pharmaceutical, Inc. | 35 | $8,209 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $2,578 |
| Teva Pharmaceuticals USA, Inc. | 58 | $2,030 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 51 | $1,870 |
| Neurocrine Biosciences, Inc. | 41 | $1,823 |
| Biohaven Pharmaceuticals, Inc. | 11 | $1,569 |
| Takeda Pharmaceuticals U.S.A., Inc. | 75 | $1,529 |
| Axsome Therapeutics, Inc. | 14 | $674 |
| Boehringer Ingelheim | 4 | $399 |
| E.r. Squibb & Sons, L.L.C. | 13 | $399 |
| Sage Therapeutics, LLC | 4 | $382 |
| Amgen | 3 | $362 |
| Novo Nordisk | 7 | $262 |
| Avanir Pharmaceuticals, Inc. | 6 | $259 |
| Merck | 7 | $231 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $215 |
| Sunovion Pharmaceuticals Inc. | 5 | $207 |
| Alkermes, Inc. | 5 | $205 |
| Eisai Inc. | 6 | $201 |
| Alfasigma USA, Inc. | 6 | $140 |
| Acadia Pharmaceuticals Inc | 2 | $140 |
| Janssen Scientific Affairs, LLC | 1 | $122 |
| Lundbeck LLC | 5 | $97 |
| Shire North American Group Inc | 4 | $81 |
| Life Molecular Imaging Ltd | 1 | $30 |
| Lilly USA, LLC | 1 | $14 |
| Indivior Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$51,027
- SPRAVATO$12,968
- ABILIFY MYCITE$7,357
- NURTEC ODT$1,439
- INGREZZA$1,016
- Auvelity$514
- LYBALVI$441
- INVEGA SUSTENNA$406
- CAPLYTA$352
- AUSTEDO$248
- UZEDY$246
- AIMOVIG$244
- UBRELVY$210
- COBENFY$208
- INVEGA TRINZA$147
- CAPVAXIVE$128
- NUPLAZID$125
- Ozempic$122
- EVENITY$118
- LATUDA$116
How this compares
$106,027 in reported general payments places this provider in the 95th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 12 | $6,274 |
| Bupropion XlBupropion Hcl | 18 | $864 |
| Quetiapine Fumarate | 24 | $635 |
| Clonazepam | 19 | $322 |
| Escitalopram Oxalate | 27 | $276 |
| Buspirone Hcl | 29 | $213 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $205 |
| Trazodone Hcl | 25 | $190 |
| Mirtazapine | 22 | $95 |
| Alprazolam | 16 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $1,529 | $6,27412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Olympia Fields
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Mark ShukhmanSkokie$250K
- Abid NazeerOak Brook$228K
- Nitin ThaparOrland Park$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.